Left ventricular dysfunction in Churg-Strauss syndrome;Linksventrikuläre dysfunktion im rahmen von Churg-Strauss-syndrom

Zeitschrift fur Kardiologie

Volumn 92, Issue 8, 2003, Pages 677-681

  Heger, Maria ^a   Bergler Klein, J ^a   Zehetgruber, M ^a   Parschalk, B ^a   Thalhammer, F ^a   Maurer, G ^a   Binder, T ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Cardimyopathy; Churg Strauss syndrome; Hypereosinophilia

Indexed keywords

ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DIGITALIS; IMMUNOSUPPRESSIVE AGENT; PHENPROCOUMON;

ADULT; ARTICLE; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CASE REPORT; CHURG STRAUSS SYNDROME; ECHOCARDIOGRAPHY; HEART LEFT VENTRICLE FUNCTION; HUMAN; HYPEREOSINOPHILIA; LUNG LAVAGE; MALE; PERICARDIAL EFFUSION; TRANSBRONCHIAL BIOPSY; VASCULITIS;

ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTI-INFLAMMATORY AGENTS; CHURG-STRAUSS SYNDROME; CORTISONE; CYCLOPHOSPHAMIDE; DRUG THERAPY, COMBINATION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ENDOMYOCARDIAL FIBROSIS; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; PLATELET AGGREGATION INHIBITORS; TIME FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0042825770     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00392-003-0962-z     Document Type: Article

References (12)

1. Abu-Shakra M, Smythe H, Lewtas J, Badley E, Weber D, Keystone E (1994) Outcome of polyarteritis nodosa and Churg-Strauss syndrome. Art Rheum 37:1798-1803
2. Baenkler HW, Fritze D, Fueßl HS, Goeckenjan G, Hamm C, Harenberg J, Hebe J, Hengstmann IH, Hörl WH, Klingmüller D, Köster R, Küchenhoff J, Kuck KH, Ludwig MM, Matzdorff A, Nienaber C, Riede UN, Rösch W, Rudolf G, Schaefer HE, Schuchert A, Schweikert HU, Siebels J, Terres W, Wahl P, Ziegler R unter der Mitarbeit von Clement U (1999) Innerer Medizin. Bewegungsapparat. Vorwiegend vaskulitische Erkrankungen: Churg Strauss Vaskulitis. Hippokrates Verlag im Thieme Verlag, Stuttgart, S 1664-1666
3. Churg J, Strauss L (1951) Allergic granulomatosis, allergic angiitis and periarteritis nodosa. Am J Pathol 27:277-301
4. Fauci AS, Harley JB, Roberts WC, Ferrans VJ, Gralnick HR, Bjornson BH (1982) NIH conference. The idiopathic hypereosinophilic syndrom. Clinical, pathophysiologic and therapeutic considerations. Ann Intern Med 97:78-92
5. Hellemans S, Dens J, Knockeart D (1997) Coronary involvement in Churg-Strauss syndrom. Heart 77:576-578
6. Kozak M, Gill EA, Green LS (1995) The Churg-Strauss syndrom. A case report with angiographically documented coronary involvement and a review of the literature. Chest 107(2):578-580
7. Lanham JG, Elkon KB, Pusey CD, Hughes GR (1984) Systemic vasculitis with asthma eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine (Baltimore) 63:65-81
8. Löffler W (1936) Endocarditis parietalis fibroplastica mit Bluteosinophilie: ein eigenartiges Krankheitsbild. Schweiz Med Wochenschr 66:817-820
9. Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY et al (1990) The American College of Rheumatology 1990 criteria for the classification of Chrug-Strauss syndrom (allergic granulomatosis and angiitis). Arthritis Rheum 33(8):1094-1100
10. McGavin CR, Marshall AJ, Lewis CT (2002) Churg-Strauss syndrom with critical endomyocardial fibrosis: 10 year survival after combined surgical and medical management. Heart 87(5):E5
11. Savage COS, Harper L, Adu D (1997) Primary systemic vasculitis. Lancet 349:553-558
12. Solans R, Bosch JA, Perez-Bocanegra C, Selva A, Huguet P, Alijotas J, Orriols R, Armadans L, Vilardell M (2001) Churg-Strauss syndrom: outcome and long-term follow-up of 32 patients. Rheumatology 40:763-771